Goldman Sachs’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.1M | Buy |
|
|||||
|
2025
Q1 | $7.85M | Sell |
|
|||||
|
2024
Q4 | $7.71M | Buy |
|
|||||
|
2024
Q3 | $7.1M | Sell |
|
|||||
|
2024
Q2 | $8.77M | Buy |
|
|||||
|
2024
Q1 | $4.2M | Buy |
|
|||||
|
2023
Q4 | $2.05M | Sell |
|
|||||
|
2023
Q3 | $4.71M | Buy |
|
|||||
|
2023
Q2 | $1.92M | Buy |
|
|||||
|
2023
Q1 | $835K | Sell |
|
|||||
|
2022
Q4 | $1.33M | Buy |
|
|||||
|
2022
Q3 | $1.24M | Sell |
|
|||||
|
2022
Q2 | $2.38M | Sell |
|
|||||
|
2022
Q1 | $3.27M | Sell |
|
|||||
|
2021
Q4 | $4.71M | Buy |
|
|||||
|
2021
Q3 | $5.02M | Buy |
|
|||||
|
2021
Q2 | $3.51M | Buy |
|
|||||
|
2021
Q1 | $2.81M | Sell |
|
|||||
|
2020
Q4 | $3.28M | Buy |
|
|||||
|
2020
Q3 | $1.29M | Buy |
|
|||||
|
2020
Q2 | $788K | Sell |
|
|||||
|
2020
Q1 | $1.79M | Buy |
|
|||||
|
2019
Q4 | $1.64M | Sell |
|
|||||
|
2019
Q3 | $1.05M | Buy |
|
|||||
|
2019
Q2 | $1.63M | Sell |
|
|||||
|
2019
Q1 | $4.8M | Sell |
|
|||||
|
2018
Q4 | $5.53M | Buy |
|
|||||
|
2018
Q3 | $6.15M | Buy |
|
|||||
|
2018
Q2 | $3.36M | Buy |
|